Date: March 18th 2014
Location; The Dorchester, London
Should we be reinventing business models? Entering new markets? Employing more innovative technologies? And what about the consideration of big data? How are changes to national healthcare, clinical trial safety and the question of R&D funding delaying progress? After 20 years of leading the Pharma debate we invite you to help define what the priorities are for the industry.
The implementation of new trends from IT points towards a solution, as do alternative ways of funding R&D through the establishment of new public-private partnerships.
With European markets moribund, frontier markets present significant growth opportunities for the industry, but accessing and tapping them is easier said than done.
In its 20th year, The Pharma Summit is established as the major industry event that brings together all major stakeholders - industry leaders, policy-makers, regulators, academics, scientists and patient representatives, innovators from IT and biotechnology as well as from frontier markets, to tackle the most pressing issues the industry is facing and to assess the power of a range of disruptive new business models.
The event in 2013 drew an audience of over 180 senior pharmaceutical executives from across the UK, Europe and beyond to debate the future of this critical sector.
For more information please visit our website: www.thepharmasummit.com